國立虎尾科技大學 |

Colon Cancer Diagnosis and Therapy = Volume 2 /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Colon Cancer Diagnosis and Therapy/ edited by Naveen Kumar Vishvakarma, Ganji Purnachandra Nagaraju, Dhananjay Shukla.
其他題名:	Volume 2 /
其他作者:	Vishvakarma, Naveen Kumar.
面頁冊數:	XIV, 453 p. 52 illus., 31 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cancer research. -
電子資源:	https://doi.org/10.1007/978-3-030-64668-4
ISBN:	9783030646684

Colon Cancer Diagnosis and Therapy = Volume 2 /
Colon Cancer Diagnosis and TherapyVolume 2 /[electronic resource] :edited by Naveen Kumar Vishvakarma, Ganji Purnachandra Nagaraju, Dhananjay Shukla. - 1st ed. 2021. - XIV, 453 p. 52 illus., 31 illus. in color.online resource.

Application of Single Cell Technology in Colorectal Cancer -- Dietary habits and global incidence of Colon Cancer -- Diet and Colon Cancer: A Comprehensive Review -- Recent therapeutic strategies for the treatment of colon cancer -- Role of bacteria in development of cancer -- Role of Bacterial infection (H. Pylori) in colon carcinogenesis and therapeutic approaches -- Diagnosis of Colorectal Cancer using Molecular Techniques -- Nanotechnology approaches for colorectal cancer diagnosis and therapy -- Natural products as immunomodulatory and chemo-sensitizing agents in colon cancer treatment -- Role of DNA mismatch repair genes in colorectal cancer -- Targeting of aerobic glycolysis: an emerging therapeutic approach against colon cancer -- An insight into therapeutic potential of phytochemicals for colorectal cancer: Latest perspective -- Sea weeds: Potential candidates in human colon cancer therapy -- Recent update on Nanomedicine based drug targeting on colon cancer -- Therapeutic targeting of glutamine metabolism in colorectal cancer -- Preventive effect of indian food on colorectal cancer -- Extracellular Vesicles in Colorectal Cancer Progress, Metastasis, Diagnosis and Therapy -- Probiotics in colon cancer: A therapeutic approach -- Index.

Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the second of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutics, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.

ISBN: 9783030646684

Standard No.: 10.1007/978-3-030-64668-4doiSubjects--Topical Terms:

1253664
Cancer research.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Colon Cancer Diagnosis and Therapy = Volume 2 /
LDR:03947nam a22003855i 4500 001 1055204
003 DE-He213
005 20211115205252.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030646684 $9 978-3-030-64668-4
024 7 $a 10.1007/978-3-030-64668-4 $2 doi
035 $a 978-3-030-64668-4
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Colon Cancer Diagnosis and Therapy $h [electronic resource] : $b Volume 2 / $c edited by Naveen Kumar Vishvakarma, Ganji Purnachandra Nagaraju, Dhananjay Shukla.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XIV, 453 p. 52 illus., 31 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Application of Single Cell Technology in Colorectal Cancer -- Dietary habits and global incidence of Colon Cancer -- Diet and Colon Cancer: A Comprehensive Review -- Recent therapeutic strategies for the treatment of colon cancer -- Role of bacteria in development of cancer -- Role of Bacterial infection (H. Pylori) in colon carcinogenesis and therapeutic approaches -- Diagnosis of Colorectal Cancer using Molecular Techniques -- Nanotechnology approaches for colorectal cancer diagnosis and therapy -- Natural products as immunomodulatory and chemo-sensitizing agents in colon cancer treatment -- Role of DNA mismatch repair genes in colorectal cancer -- Targeting of aerobic glycolysis: an emerging therapeutic approach against colon cancer -- An insight into therapeutic potential of phytochemicals for colorectal cancer: Latest perspective -- Sea weeds: Potential candidates in human colon cancer therapy -- Recent update on Nanomedicine based drug targeting on colon cancer -- Therapeutic targeting of glutamine metabolism in colorectal cancer -- Preventive effect of indian food on colorectal cancer -- Extracellular Vesicles in Colorectal Cancer Progress, Metastasis, Diagnosis and Therapy -- Probiotics in colon cancer: A therapeutic approach -- Index.
520 $a Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the second of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutics, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.
650 0 $a Cancer research. $3 1253664
650 0 $a Immunology. $3 592892
650 0 $a Medicine. $3 644133
650 1 4 $a Cancer Research. $3 668358
650 2 4 $a Biomedicine, general. $3 1253757
700 1 $a Vishvakarma, Naveen Kumar. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1360374
700 1 $a Nagaraju, Ganji Purnachandra. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1198408
700 1 $a Shukla, Dhananjay. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1360375
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030646677
776 0 8 $i Printed edition: $z 9783030646691
856 4 0 $u https://doi.org/10.1007/978-3-030-64668-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)